Maase
MAAS
12.40
+0.45
+3.77%
Maase
US · MAAS
#1915 by market cap
Listed 1970
12.40
+0.45
+3.77%
Live - 5344 symbols - heartbeat 395s ago
· 2026-10-08 06:23
Pre-market
12.40
0.00%
After-hours
12.40
0.00%
- Market cap
- 5.48B
- P/E (TTM)i
- -11.68
- P/Bi
- 10.99
- EPSi
- -3.88
- Div yieldi
- 0.00%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on MAAS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.04, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -18.89% YoY
Margins
- Gross margin
- 49.14%
- Operating margin
- -32.01%
- Net margin
- -25.08%
Key ratios & quality
- Altman Z-Scorei
- 3.04
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 165.81M | 203.23M | 129.48M | 191.20M | 188.74M | 114.44M | 963.21M | 781.22M |
| Gross profit | 136.99M | 172.14M | 97.72M | 147.16M | 133.68M | 94.16M | 394.93M | 383.86M |
| Selling & admin expenses | 74.09M | 116.06M | 151.25M | 220.34M | 207.79M | 152.96M | 431.99M | 633.90M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 63.09M | 56.34M | -48.45M | -68.49M | -74.10M | -58.80M | -37.05M | -250.04M |
| Pretax profit | 71.88M | 61.42M | -35.95M | -55.67M | -61.59M | -34.99M | -501.10M | -352.37M |
| Tax | 8.26M | 9.40M | -2.39M | -9.61M | -925.00K | 8.59M | 13.53M | -19.64M |
| Net profit | 63.62M | 52.02M | -33.55M | -46.07M | -60.67M | -43.58M | -512.07M | -458.90M |
| Basic EPS | 46 | 38 | -22 | -31 | -40 | -43 | -112 | -26 |
| Diluted EPS | 46.12 | 37.80 | -21.84 | -30.78 | -40.26 | -43.35 | -113.55 | -26.03 |
| Line item | 2023-06 | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 214.57M | 467.12M | 393.22M | 403.33M | 394.76M | 231.01M | 2.39B | 2.20B |
| Cash & ST investments | 118.88M | 380.45M | 289.92M | 260.59M | 199.26M | 164.47M | 807.97M | 630.25M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 225.87M | 479.41M | 432.71M | 467.90M | 463.94M | 264.54M | 4.28B | 3.37B |
| Total current liabilities | 32.21M | 75.83M | 47.52M | 130.29M | 167.13M | 24.08M | 850.99M | 573.99M |
| Short-term debt | -- | -- | 7.40M | 13.71M | 11.89M | 4.79M | 145.65M | 111.32M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 32,214,000.00 | 75,833,000.00 | 62,230,000.00 | 147,602,000.00 | 203,885,000.00 | 47,509,000.00 | 1,683,964,000.00 | 1,225,804,000.00 |
| Total equity | 193.65M | 403.58M | 370.48M | 320.30M | 260.05M | 217.03M | 2.59B | 2.14B |
| Retained earnings | 107.41M | 155.27M | 120.31M | 72.71M | 11.84M | -31.50M | -321.25M | -517.37M |
| Line item | 2023-06 | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 |
|---|---|---|---|---|---|---|
| Total current assets | 231.01M | 2.59B | 2.39B | 2.24B | 2.20B | 2.25B |
| Cash & ST investments | 164.47M | 1.56B | 807.97M | 889.02M | 630.25M | 34.59M |
| Inventory | -- | -- | -- | -- | -- | 1.98B |
| Total assets | 264.54M | 4.98B | 4.28B | 4.56B | 3.37B | 3.45B |
| Total current liabilities | 24.08M | 1.04B | 850.99M | 832.61M | 573.99M | 42.42M |
| Short-term debt | 4.79M | 225.91M | 145.65M | 175.11M | 111.32M | 12.75M |
| Long-term debt | -- | -- | -- | -- | -- | 1.16M |
| Total liabilities | 47,509,000.00 | 1,857,596,000.00 | 1,683,964,000.00 | 1,654,168,000.00 | 1,225,804,000.00 | 110,187,000.00 |
| Total equity | 217.03M | 3.12B | 2.59B | 2.91B | 2.14B | 3.34B |
| Retained earnings | -31.50M | -64.84M | -321.25M | -89.28M | -517.37M | -1.50B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 44.92M | 98.04M | -88.75M | -2.83M | -56.16M | -25.36M | 57.73M | 71.47M |
| Depreciation & amortization | 1.87M | 1.74M | 9.12M | 13.64M | 6.44M | 4.39M | 59.21M | 101.64M |
| Free cash flow | 43.52M | 93.20M | -92.37M | -11.87M | -61.75M | -27.24M | 53.43M | 65.29M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 163.36M | -- | -- | 0 | 0 | 34.94M | 3.00M |
| Ending cash balance | 112.00M | 430.27M | 288.89M | 332.78M | 194.26M | 164.47M | 370.40M | 105.32M |
| Line item | 2023-06 | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 38.74 | 18.30 | -8.56 | -13.47 | -20.91 | -18.27 | -38.57 | -20.40 |
| ROA %i | 30.94 | 15.18 | -7.21 | -10.30 | -13.02 | -11.85 | -12.73 | -5.13 |
| ROIC %i | 36.81 | 16.87 | -10.63 | -14.95 | -21.04 | -18.99 | -34.88 | -19.55 |
| 5-year avg ROE %i | -- | -- | -- | 12.08 | 2.82 | -8.58 | -19.96 | -22.32 |
| EBIT margin %i | 43.35 | 30.74 | -27.76 | -29.12 | -36.59 | -49.93 | -2.90 | -32.01 |
| FCF / sales %i | 26.25 | 45.86 | -- | -- | -- | -- | 4.51 | 8.36 |
| Current ratioi | 6.66 | 6.16 | 8.27 | 3.10 | 2.36 | 9.59 | 2.80 | 3.84 |
| Quick ratioi | 6.22 | 5.40 | 8.09 | 2.43 | 1.57 | 9.22 | 2.48 | 3.78 |
| Debt / assetsi | -- | 0.00 | 5.11 | 6.63 | 7.58 | 5.47 | 4.66 | 4.20 |
| LT debt / equityi | -- | -- | 4.00 | 5.40 | 8.94 | 4.46 | 4.19 | 4.70 |
| Interest coveragei | -- | 59.61 | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -5.96 | 4.86 | -2.44 | -4.03 | 71.43 | 60.56 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2023-06 | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 |
|---|---|---|---|---|---|---|
| ROE %i | -18.27 | -5.21 | -38.57 | -1.68 | -20.40 | -96.34 |
| ROA %i | -11.85 | -1.71 | -12.73 | -0.51 | -5.13 | -56.84 |
| ROIC %i | -18.99 | -4.89 | -34.88 | -2.44 | -19.55 | -91.89 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -49.93 | -56.75 | -2.90 | -7.90 | -32.01 | -34.24 |
| FCF / sales %i | -- | -- | 4.51 | -- | 8.36 | -- |
| Current ratioi | 9.59 | 2.48 | 2.80 | 2.69 | 3.84 | 53.07 |
| Quick ratioi | 9.22 | 2.31 | 2.48 | 2.61 | 3.78 | 6.34 |
| Debt / assetsi | 5.47 | 6.12 | 4.66 | 4.68 | 4.20 | 0.44 |
| LT debt / equityi | 4.46 | 5.19 | 4.19 | 2.77 | 4.70 | 0.07 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Insurance Agency is the largest reported line at 93.13% of revenue, across 2 reported segments.
- The next-largest line, Wealth Management, is a distant second at 6.87% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Insurance Agency93.13%
Wealth Management6.87%
Region
People’s Republic of China (PRC)100.00%
Quote time 2026-10-08 06:23:56 · For reference only, not investment advice and not tailored to your situation.